Completed PHASE1 INTERVENTIONAL 1-arm NCT00707499

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

A Single-Dose, Phase I, Dosimetry, Biodistribution, and Safety Trial of BMS 747158 in Healthy Subjects

Sponsor: Lantheus Medical Imaging

Conditions Healthy

Interventions BMS747158

Updated 7 times since 2017 Last updated: Nov 6, 2020 Started: Sep 30, 2007 Primary completion: May 31, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Lantheus Medical Imaging leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Dec 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Dec 2020 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lantheus Medical Imaging

Data source: Lantheus Medical Imaging

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States